Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
IQ Capital investment portfolio
IQ Capital has made numerous investments in companies such as Imperagen, Nyobolt, and Risilience within the Biotech sector.
vc
Portfolio
18
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (18)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Baseimmune Ltd Baseimmune creates AI‑driven, computationally designed antigen therapeutics using advanced protein‑engineering techniques, delivering next‑generation active immunotherapies for chronic diseases. Its platform is marketed to pharmaceutical and biotech firms developing vaccines and immunotherapy | Healthcare & Life Sciences | London | Confirmed | 2025-10-29 |
| Boltzbit Limited Boltzbit builds custom generative‑AI models that continuously learn from user data, branded as General Learning Intelligence (GLI) or AGI 2.0, and delivers these adaptive AI solutions to enterprise customers, notably in financial services, data‑intensive businesses and high‑growth technology sectors. It also provides AI research and integration services that enable organisations to own, train and control their own live‑learning models. | Software & IT | London | Confirmed | 2026-01-12 |
Shareholding changes (11)
Iq Capital Partners Nominee Limited's positions across portfolio companies2026
- A ORDINARY 0 → 18,554
- PRE-SEED 1 ORDINARY 0 → 198,269
Articles (3)
- 3 Jun 2026
- 9 May 2026
- 2 May 2026